Yakira Capital Management’s scPharmaceuticals SCPH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-438,355
Closed -$2.49M 220
2025
Q3
$2.49M Buy
+438,355
New +$2.24M 0.87% 35

Yakira Capital Management's SCPH Position: Q4 2025 in Review

Yakira Capital Management sold out of scPharmaceuticals (SCPH) in Q4 2025, closing a stake of 438,355 shares — an estimated $2.49M sold.

Yakira Capital Management first reported a position in SCPH in Q3 2025 and held it in 1 quarter. The position peaked at $2.49M in Q3 2025. 0 funds tracked by Wall St. Rank hold SCPH as of Q4 2025.

  • Yakira Capital Management reported no remaining scPharmaceuticals position as of Q4 2025 after selling out during the quarter.
  • Yakira Capital Management sold 438,355 scPharmaceuticals shares in Q4 2025, an estimated $2.49M.
  • Yakira Capital Management first reported a position in scPharmaceuticals in Q3 2025 and held it in 1 quarter.
  • Yakira Capital Management's scPharmaceuticals position peaked at $2.49M in Q3 2025.
  • 0 funds tracked by Wall St. Rank held scPharmaceuticals as of Q4 2025.

Based on Yakira Capital Management's 13F filing for Q4 2025, filed 13 Feb 2026.